Catalyst Wire Dossier Catalyst Wire Dossier

TUDORZA PRESSAIR

ACLIDINIUM BROMIDE · Covis Pharma US, Inc
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for TUDORZA PRESSAIR, covering 2012-07-23 to 2019-03-29. Get the full timeline:

Most recent: FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)

See pricing